PRODIGY — Multimodal AI Diagnostics for Prostate Cancer

Digital pathology · Multimodal AI · Digital twins

A clearer picture of prostate cancer.

PRODIGY brings together researchers in Greece and China to explore how digital pathology, explainable artificial intelligence, and digital twins can support more informed diagnosis.

PRODIGY — Multimodal AI Diagnostics for Prostate Cancer

A Greece–China research collaboration

University of Piraeus · Fudan University · BioAssist S.A.

Connecting data. Advancing understanding.

From microscopic tissue images to a broader view of disease, our research connects complementary sources of medical information.

01 / Digital pathology

Learning from tissue

Investigating image analysis for disease classification, Gleason grading, and the detection of defects in digital pathology images.

02 / Multimodal AI

Bringing evidence together

Studying how imaging, clinical, genomic, and text data can contribute to disease modelling and prognostic research.

03 / Digital twins

Modelling disease progression

Developing digital representations to explore the evolution of prostate cancer, with explainable predictions and expert feedback.

Built on collaboration.

University of Piraeus, Fudan University, and BioAssist S.A. contribute complementary expertise in computing, digital medicine, and healthcare technology.

Meet the partners →

Research objectives, not established clinical outcomes. Public findings will be shared as they become available.

Latest from PRODIGY

No approved content has been published yet. Please check back for project updates.

PRODIGY
Privacy overview

Only essential cookies are used for language and cookie settings. No analytics or advertising cookies are enabled.

Privacy & cookies